CD274 and neoplasm: Intriguingly, a recent study found that knocking down PD-L1 can reduce the expression of hexokinase-2, an enzyme critical for glycolysis, and inhibit the PI3K/AKT/mTOR and ERK pathways, which are key drivers of tumor growth and survival [41].